Seres Therapeutics Inc
(MCRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2014 | 03-2014 | 12-2013 | 12-2012 | |
| Operating Expenses | 2,618 | 1,672 | 0 | 0 |
| Operating Income | -2,618 | -1,672 | N/A | N/A |
| Other Income | -59 | -17 | 0 | 0 |
| Pre-tax Income | -2,677 | -1,689 | 0 | 0 |
| Net Income Continuous | -2,677 | -1,689 | N/A | N/A |
| Net Income | $-2,677 | $-1,689 | $N/A | $N/A |
| EPS Basic Total Ops | -9.00 | -5.80 | N/A | N/A |
| EPS Basic Continuous Ops | -7.96 | -5.05 | N/A | N/A |
| EPS Diluted Total Ops | -9.00 | -5.80 | N/A | N/A |
| EPS Diluted Continuous Ops | -7.96 | -5.05 | N/A | N/A |
| EBITDA(a) | $-2,582 | $-1,642 | $N/A | $N/A |